Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain — Stella

Home/Brain Glioma/

View on ClinicalTrials.gov

Recruiting

Back to Brain Glioma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Key details

Sponsor

The First Affiliated Hospital of Zhengzhou University

Enrollment target

~20 participants

Started

March 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.